SCHEMBL1710073

SCHEMBL1710073

Cc1ccc(SCCO)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA7 P43166 1/20 0.52
CA13 Q8N1Q1 1/20 0.52
ALDH1A1 P00352 5/20 0.50
MAPK1 P28482 1/20 0.50
HPGD P15428 9/20 0.49
MAPT P10636 3/20 0.48
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 1/20 0.44
ALOX12 P18054 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23930344 0.90 NPC1 (0.49) NPC1RAB9ACA12CA1CA2
SCHEMBL8637757 0.87 CA2 (0.61) NPC1RAB9ACA12CA1CA2
SCHEMBL2450821 0.87 ALDH1A1 (0.57) CA12CA1CA2CA7CA13
SCHEMBL5825613 0.86 CA2 (0.55) NPC1RAB9ACA2ALDH1A1MAPK1
SCHEMBL5168911 0.85 NPC1 (0.65) NPC1RAB9AALDH1A1MAPK1HPGD
SCHEMBL26121323 0.83 CA2 (0.57) NPC1RAB9ACA2ALDH1A1MAPK1
SCHEMBL8529367 0.80 CA2 (0.55) NPC1RAB9ACA12CA1CA2
SCHEMBL10862531 0.80 HPGD (0.47) NPC1RAB9AALDH1A1MAPK1HPGD
SCHEMBL3900894 0.80 CA2 (0.55) NPC1RAB9ACA12CA1CA2
SCHEMBL5172043 0.80 POLB (0.56) NPC1RAB9AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118580164-A Preparation method of sulfoxide derivative 华侨大学 2024-09-03 CN claimed
EP-2748143-A1 MONOMERIC AND OLIGOMERIC UNSATURATED VICINAL DITHIOETHERS AND THEIR USE FOR SELECTIVE PALLADIUM (II) SEPARATION FROM SECONDARY RAW MATERIALS Universität Potsdam (DE) 2014-07-02 EP claimed
WO-2013026885-A1 MONOMERIC AND OLIGOMERIC UNSATURATED VICINAL DITHIOETHERS AND THEIR USE FOR SELECTIVE PALLADIUM (II) SEPARATION FROM SECONDARY RAW MATERIALS UNIVERSITÄT POTSDAM (DE) 2013-02-28 WO claimed
CN-122039074-A Method for preparing sulfoxide compound by electrochemical microchannel continuous flow oxidation 南京工业大学 2026-05-15 CN disclosed
US-20250135059-A1 COMPOSITIONS COMPRISING FRAGRANCE MATERIALS THE PROCTER & GAMBLE COMPANY 2025-05-01 US disclosed
CN-118580164-A Preparation method of sulfoxide derivative 华侨大学 2024-09-03 CN disclosed
US-11693310-B2 Blue curable resin composition, blue color filter, and display device including same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-04 US disclosed
US-11693310-B2 Blue curable resin composition, blue color filter, and display device including same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-04 US disclosed
WO-2023001108-A1 PREPARATION OF HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 成都赜灵生物医药科技有限公司 2023-01-26 WO disclosed
US-20200371435-A1 BLUE CURABLE RESIN COMPOSITION, BLUE COLOR FILTER, AND DISPLAY DEVICE INCLUDING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-11-26 US disclosed
US-9051397-B2 Oxime ester BASF SE (DE) 2015-06-09 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20060009627-A1 Azo compound, tautomer thereof, and azo dye FUJI PHOTO FILM CO., LTD. 2006-01-12 US disclosed
US-20040220054-A1 Recording material FUJI PHOTO FILM CO., LTD. 2004-11-04 US disclosed
EP-1473591-A1 Recording material FUJI PHOTO FILM CO., LTD. (JP) 2004-11-03 EP disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed
EP-0382213-B1 Biphenyl derivative, nerve cell degeneration repairing or protecting agent and process for preparing a phenyl derivative contained in the agent OTSUKA PHARMA CO LTD (JP) 1995-05-10 EP disclosed
US-5053548-A Containing hydroxy substituents; nervous system disorders OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) 1991-10-01 US disclosed
EP-0382213-A2 Biphenyl derivative, nerve cell degeneration repairing or protecting agent and process for preparing a phenyl derivative contained in the agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA NPC1 4167/4885RAB9A 1208/4885CA12 4885/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA NPC1 4076/4885RAB9A 1132/4885CA12 4885/4885
US-20060009627-A1 Azo compound, tautomer thereof, and azo dye NR4A1, PRMT7, NR0B1 NPC1 3364/4885RAB9A 3145/4885CA12 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.